Respiratory Viral Infection
42
3
6
23
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.5%
4 terminated out of 42 trials
85.2%
-1.3% vs benchmark
24%
10 trials in Phase 3/4
26%
6 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (42)
Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza
Dime La VerDAD: Verify, Debunk, and Disseminate
Wells and Enteric Disease Transmission
Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Wells and Enteric Disease Transmission Trial (WET - Trial)
Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza
Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males
Reducing Respiratory Virus Transmission in Bangladeshi Classrooms
Zinc and Green Tea Extract for Community Respiratory Viral Infections
Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza
Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)
The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 Analyzer
COVID-19 Testing Sample Acquisition Throughput and Efficiency
A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections